Drug
Ralinepag
Ralinepag: highest development phase Phase 3, developed by United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ralinepag NCT03683186 | Phase 3 | PAH |
| Ralinepag NCT04084678 | Phase 3 | Pulmonary Hypertension |
Latest
No recent events.
Follow Ralinepag on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.